VO

Vipul Organics Ltd

Q4 FY26Chemicals & Petrochemicals

Vipul Organics Q4 FY26 investor presentation: Revenue & Margins

Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹269
Market cap₹512 Cr
P/E62.7
Updated27 Sept 2026
Read3 min read

Based on Vipul Organics Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) - Q4 FY25 (Mar 2025) total revenue: ₹4,397.55 lakhs (Consolidated) - Year-on-Year (YoY) revenue growth: ▲19.67% - Quarterly QoQ r The presentation does not explicitly report EBITDA or operating margin figures for the quarter.

From Vipul Organics Ltd's Q4 FY26 earnings-call transcript · updated 27 Sept 2026.

Revenue & Sales Performance

  • Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated)
  • Q4 FY25 (Mar 2025) total revenue: ₹4,397.55 lakhs (Consolidated)
  • Year-on-Year (YoY) revenue growth: ▲19.67%

2 more points management made on revenue & sales performance

Profitability & Margins

See what Vipul Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Sayakha Plant (Gujarat)
  • Status: Acquisition of plot in 2021; commencement planned in 2026
  • Details: New plant start-up mentioned in milestones (Page 5)
  • Membrane & Water Treatment Vertical
  • R&D: 3+ years completed with in-house membrane developed
  • Market: Global $7.41B (2025) growing to $11.48B (2033) at 5.62% CAGR
  • Plans: Exhibitions planned overseas and in Mumbai in next 3 months (Page 28)
  • New Product Category - Organic Intermediate for Automotive Industry
  • Status: First commercial order fulfilled after 18 months approval
  • Outlook: Expect increasing demand, establishing robust revenue stream (Page 27)

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Vipul Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided presentation pages do not explicitly mention any details regarding the company's order book, order inflow, or pending orders. Specifically: - There is no stated figure or commentary on current order book size. - No explicit information is provided on order inflow rates or volumes. - Pending orders or backlog data are not disclosed anywhere in the shared content. The presentation primarily focuses on financial results, market positioning, product expansion, certifications, export markets, and strategic initiatives without reference to specific order status or pipeline metrics.

Vipul Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹46 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Vipul Organics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Chemfab Alka. (Q4 FY26)

    Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key investor presentation takeaways from Chemfab Alkalis Ltd's Q4 FY26 investor presenta

  • Sudarshan Pharma Industries Ltd (Q4 FY26)

    Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key investor presentation takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 investor pr

  • Innovassynth Technologies (India) Ltd (Q4 FY26)

    Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key investor presentation takeaw

  • Jubilant Agri (Q4 FY26)

    Q4 FY26 Revenue from Operations: INR 4,852 MN, up 22% YoY from INR 3,983 MN in Q4 FY25 (Page 19) . Key investor presentation takeaways from Jubilant Agri & Cons

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Vipul Organics Ltd Q4 FY26 results?

Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) - Q4 FY25 (Mar 2025) total revenue: ₹4,397.55 lakhs (Consolidated) - Year-on-Year (YoY) revenue growth: ▲19.67% - Quarterly QoQ r The presentation does not explicitly report EBITDA or operating margin figures for the quarter.

What is Vipul Organics Ltd share price analysis?

Vipul Organics Ltd currently shows a neutral. The stock trades at a P/E of 62.7 with a market cap of ₹512 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vipul Organics Ltd planning capital expenditure?

Sayakha Plant (Gujarat) - Status: Acquisition of plot in 2021; commencement planned in 2026 - Details: New plant start-up mentioned in milestones (Page 5) - Membrane & Water Treatment V

Keep Vipul Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.